60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria

<p>60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035 for tafenoquine for prevention of Plasmodium falciparum malaria in naïve individuals Tafenoquine kills dormant liver stage of P. vivax parasite and clears the blood stages of P. falciparum WASHINGTON, Aug. 22, 2023 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals (“60P”) (Nasdaq: SXTP), […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/60-degrees-pharmaceuticals-receives-additional-u-s-patent-covering-tafenoquine-for-prevention-of-plasmodium-falciparum-malaria/">60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>